GL1X · GenesisL1 explorer

Research workbench

Solution NMR structure of tryptophan to alanine mutant of arkadia ring domain.

Analyse Solution NMR structure of tryptophan to alanine mutant of arkadia ring domain. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5LG0
Type
protein
Length
69 residues
Chains
1
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
E3 ubiquitin-protein ligase arkadia
EC
6.3.2.-
UniProt
Q6ZNA4
Ligands
ZN
Pockets
1 · best druggability 0.31

Structure

solution nmr · 1 distinct chain · 14% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AE3 ubiquitin-protein ligase arkadia (EC 6.3.2.-)protein6914% helix, 20% strandQ6ZNA4

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1640.310.7515empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 5LG0 · Solution NMR structure of Tryptophan to Alanine mutant of Arkadia RING domain. · the same entry in another collection · chain A against A, TM-score 1.00
  • Q6ZNA4 · AlphaFold monomer V2.0 prediction for E3 ubiquitin-protein ligase arkadia (Q6ZNA4) · a predicted model of the same protein · chain A against A, TM-score 0.69

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.